Insmed Inc (INSM)

[io_io]

elmono .............


"<<< I would be very very surprised if in the next weeks a full and final settlement will be reached.>>>"



Actually I am surprised this has gone so far. I thought that perhaps DNA would not risk publicity of a trial like this. But maybe that is something that INSM played into. There is still time, and even last wekk something was to be put on the table.

By the way, I agree with most other things you say, and I welcome your comments very much. It was thought that Iplex would quickly differentiate itself from Increlex, and in fact at first it seemed to, but these results (at least as published) are not so stellar. It would take a new development (truly excellent phase II results, or a partnership) to get us moving again, barring a trial victory.